Profil
Yueh Hsin Lai is currently a Director-Supervisory Board at CytoPharm, Inc. and a Director at Tai Hsin Venture Capital Co., Ltd., Fu Yung Biotechnology Co. Ltd., and Fu Yung Investment Co. Ltd.
Previously, Lai was a Director at EPS Bio Technology Corp.
Postes actifs de Yueh Hsin Lai
| Sociétés | Poste | Début |
|---|---|---|
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Directeur/Membre du Conseil | 22/09/2011 |
| Fu Yung Biotechnology Co. Ltd. | Directeur/Membre du Conseil | 22/09/2011 |
| Fu Yung Investment Co. Ltd. | Directeur/Membre du Conseil | 22/09/2011 |
| Tai Hsin Venture Capital Co., Ltd. /Taiwan/ | Directeur/Membre du Conseil | - |
Anciens postes connus de Yueh Hsin Lai
| Sociétés | Poste | Fin |
|---|---|---|
| EPS BIO TECHNOLOGY CORP. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EPS BIO TECHNOLOGY CORP. | Health Technology |
| Entreprise privées | 4 |
|---|---|
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
| Fu Yung Biotechnology Co. Ltd. | |
| Fu Yung Investment Co. Ltd. | |
| Tai Hsin Venture Capital Co., Ltd. /Taiwan/ |
